IP Library Assignment 051659/0531
Patent Assignment
Reel/Frame 051659/0531

Assignment of Assignor's Interest

Recorded: 2020-01-29 Pages: 6
Assignor
Assignee
NOVOCURE (ISRAEL) LTD.
TOPAZ BUILDING 4TH FLOOR, MATAM CENTER, HAIFA, 31905, ISRAEL
Covered Properties (4)
Methods for Reducing Viability of Cancer Cells by Activation of the Sting Pathway with Ttfields
Application: 16/673,246 →
Publication: US 2021/0069503
Inhibiting Prostaglandin E Receptor 3 Resensitizes Resistant Cells to TTFields
Application: 62/826,078 →
Inhibiting Prostaglandin E Receptor 3 Resensitizes Resistant Cells to TTFields and Prevents Cells from Developing Resistance to TTFields
Application: 62/849,535 →
Methods for Reducing Viability of Cancer Cells by Activation of the STING Pathway with TTFields
Application: 62/898,290 →
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 11, 2019
From: TRAN, DAVID; LE, SON BANG; CHEN, DONGJIANG
To: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
Reel/Frame 050342/0177 →
Assignment of Assignor's Interest Sep 11, 2019
From: TRAN, DAVID; LE, SON BANG; CHEN, DONGJIANG
To: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
Reel/Frame 050342/0240 →
Assignment of Assignor's Interest Sep 18, 2019
From: TRAN, DAVID; CHEN, DONGJIANG
To: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
Reel/Frame 050415/0723 →
Assignment of Assignor's Interest Jan 29, 2020
From: TRAN, DAVID; CHEN, DONGJIANG
To: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
Reel/Frame 051659/0319 →
Assignment of Assignor's Interest Jan 29, 2020
From: NOVOCURE (ISRAEL) LTD.
To: NOVOCURE GMBH
Reel/Frame 051735/0725 →
Security Interest Nov 6, 2020
From: NOVOCURE GMBH
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 054344/0510 →
Release of Security Interest Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
Patent Security Agreement May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →